Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Boehringer Ingelheim
Daiichi Sankyo
Harvard Business School
Moodys
Johnson and Johnson
Baxter
Citi
McKesson

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,951,639

« Back to Dashboard

Title: 1,4,7,10-tetraazacyclododecane butyltriols, processes for their production and pharmaceutical agents containing them
Abstract:1,4,7,10-Tetraazacyclodedecane butyltriols of general formula I.sub.A ##STR1## in which R.sup.1 means hydrogen or a metal ion equivalent independent of one another and R.sup.2 means a butyltriol radical as well as their salts with organic or inorganic bases or amino acids are valuable pharmaceutical agents.
Inventor(s): Platzek; Johannes (Berlin, DE), Gries; Heinz (Berlin, DE), Weinmann; Hanns-Joachim (Berlin, DE), Schuhmann-Giampieri; Gabriele (Berlin, DE), Press; Wolf-Rudiger (Berlin, DE)
Assignee: Schering AG (Berlin, DE)
Filing Date:Apr 09, 2002
Application Number:10/118,430
Claims:1. A method of performing in vivo NMR spectroscopy in a patient comprising administering a compound as a susceptibility agent which has the formula I.sub.A ##STR8##

in which each R.sup.1 is hydrogen or a metal ion equivalent, independent of one another and R.sup.2 is butyltriol or a salt thereof with an organic or inorganic base or an amino acid, and at least two of the substitutens R.sup.1 are metal ion equivalents.

2. A method of radiation therapy of a patient comprising administering as a photon and electron emitting agent, a compound which has the formula I.sub.A ##STR9##

in which each R.sup.1 is hydrogen or a metal ion equivalent, independent of one another and R.sup.2 is butyltriol or a salt thereof with an organic or inorganic base or an amino acid, and at least two of the substitutens R.sup.1 are metal ion equivalents.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Teva
Fuji
Dow
Argus Health
Express Scripts
Accenture
Cipla
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.